182 related articles for article (PubMed ID: 1321565)
1. Structural characterization of the mesangial cell type IV collagenase and enhanced expression in a model of immune complex-mediated glomerulonephritis.
Lovett DH; Johnson RJ; Marti HP; Martin J; Davies M; Couser WG
Am J Pathol; 1992 Jul; 141(1):85-98. PubMed ID: 1321565
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-beta 1 stimulates glomerular mesangial cell synthesis of the 72-kd type IV collagenase.
Marti HP; Lee L; Kashgarian M; Lovett DH
Am J Pathol; 1994 Jan; 144(1):82-94. PubMed ID: 8291614
[TBL] [Abstract][Full Text] [Related]
3. Expression of MMP-9 in mesangial cells and its changes in anti-GBM glomerulonephritis in WKY rats.
Kuroda T; Yoshida Y; Kamiie J; Kovalenko P; Nameta M; Fujinaka H; Yaoita E; Endo T; Ishizuka S; Nakabayashi K; Yamada A; Nagasawa T; Yamamoto T
Clin Exp Nephrol; 2004 Sep; 8(3):206-15. PubMed ID: 15480897
[TBL] [Abstract][Full Text] [Related]
4. Decreased collagen-degrading activity could be a marker of prolonged mesangial matrix expansion.
Tomita M; Koike H; Han GD; Shimizu F; Kawachi H
Clin Exp Nephrol; 2004 Mar; 8(1):17-26. PubMed ID: 15067512
[TBL] [Abstract][Full Text] [Related]
5. A novel rat mesangial matrix protein, MMP-50/100, involved in mesangial glomerulopathies.
Kootstra CJ; Arkema A; Hogendoorn PC; Daha MR; Weening JJ; Parwaresch MR; Dijkstra CD; de Heer E
Lab Invest; 1995 Jul; 73(1):72-80. PubMed ID: 7603043
[TBL] [Abstract][Full Text] [Related]
6. Human mesangial cells secrete a GBM-degrading neutral proteinase and a specific inhibitor.
Martin J; Davies M; Thomas G; Lovett DH
Kidney Int; 1989 Nov; 36(5):790-801. PubMed ID: 2559235
[TBL] [Abstract][Full Text] [Related]
7. Homology cloning of rat 72 kDa type IV collagenase: cytokine and second-messenger inducibility in glomerular mesangial cells.
Marti HP; McNeil L; Davies M; Martin J; Lovett DH
Biochem J; 1993 Apr; 291 ( Pt 2)(Pt 2):441-6. PubMed ID: 7916617
[TBL] [Abstract][Full Text] [Related]
8. Changes in serum concentrations of matrix metalloproteinases, tissue inhibitors of metalloproteinases and type IV collagen in patients with various types of glomerulonephritis.
Akiyama K; Shikata K; Sugimoto H; Matsuda M; Shikata Y; Fujimoto N; Obata K; Matsui H; Makino H
Res Commun Mol Pathol Pharmacol; 1997 Feb; 95(2):115-28. PubMed ID: 9090749
[TBL] [Abstract][Full Text] [Related]
9. Alpha8 integrin in glomerular mesangial cells and in experimental glomerulonephritis.
Hartner A; Schöcklmann H; Pröls F; Müller U; Sterzel RB
Kidney Int; 1999 Oct; 56(4):1468-80. PubMed ID: 10504498
[TBL] [Abstract][Full Text] [Related]
10. P2 receptor antagonist PPADS inhibits mesangial cell proliferation in experimental mesangial proliferative glomerulonephritis.
Rost S; Daniel C; Schulze-Lohoff E; Bäumert HG; Lambrecht G; Hugo C
Kidney Int; 2002 Nov; 62(5):1659-71. PubMed ID: 12371966
[TBL] [Abstract][Full Text] [Related]
11. Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines.
Mackay AR; Ballin M; Pelina MD; Farina AR; Nason AM; Hartzler JL; Thorgeirsson UP
Invasion Metastasis; 1992; 12(3-4):168-84. PubMed ID: 1284126
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a glomerular epithelial cell metalloproteinase as matrix metalloproteinase-9 with enhanced expression in a model of membranous nephropathy.
McMillan JI; Riordan JW; Couser WG; Pollock AS; Lovett DH
J Clin Invest; 1996 Feb; 97(4):1094-101. PubMed ID: 8613533
[TBL] [Abstract][Full Text] [Related]
13. Mesangial cells from transgenic mice with progressive glomerulosclerosis exhibit stable, phenotypic changes including undetectable MMP-9 and increased type IV collagen.
Jacot TA; Striker GE; Stetler-Stevenson M; Striker LJ
Lab Invest; 1996 Dec; 75(6):791-9. PubMed ID: 8973474
[TBL] [Abstract][Full Text] [Related]
14. Molecular characterization of a low-molecular-mass matrix metalloproteinase secreted by glomerular mesangial cells as PUMP-1.
Marti HP; McNeil L; Thomas G; Davies M; Lovett DH
Biochem J; 1992 Aug; 285 ( Pt 3)(Pt 3):899-905. PubMed ID: 1497627
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinases and mesangial remodeling in light chain-related glomerular damage.
Keeling J; Herrera GA
Kidney Int; 2005 Oct; 68(4):1590-603. PubMed ID: 16164636
[TBL] [Abstract][Full Text] [Related]
16. Identification and independent regulation of human mesangial cell metalloproteinases.
Martin J; Knowlden J; Davies M; Williams JD
Kidney Int; 1994 Sep; 46(3):877-85. PubMed ID: 7996810
[TBL] [Abstract][Full Text] [Related]
17. Coexpression of a novel glomerular basement membrane matrix material in mesangial cell culture and glomerulosclerosis.
Yang AH; Wang JS
Exp Mol Pathol; 1995 Apr; 62(2):83-98. PubMed ID: 8549699
[TBL] [Abstract][Full Text] [Related]
18. Distinct expression of gelatinase A [matrix metalloproteinase (MMP)-2], collagenase-3 (MMP-13), membrane type MMP 1 (MMP-14), and tissue inhibitor of MMPs type 1 mediated by physiological signals during formation and regression of the rat corpus luteum.
Liu K; Olofsson JI; Wahlberg P; Ny T
Endocrinology; 1999 Nov; 140(11):5330-8. PubMed ID: 10537164
[TBL] [Abstract][Full Text] [Related]
19. Monocyte adhesion to mesangial matrix modulates cytokine and metalloproteinase production.
Chana RS; Martin J; Rahman EU; Wheeler DC
Kidney Int; 2003 Mar; 63(3):889-98. PubMed ID: 12631069
[TBL] [Abstract][Full Text] [Related]
20. Glomerulosclerosis in the rat induced by repeated immune-mediated mesangial cell injury.
Iida H; Izumino K; Asaka M; Entani C; Takata M; Johnson RJ
Nihon Jinzo Gakkai Shi; 1993 Aug; 35(8):905-12. PubMed ID: 7902884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
